Valuation: Hofseth BioCare ASA

Market Cap 749M 76.22M 66.63M 61.24M 57.08M 108M 7.26B 110M 735M 286M 3.57B 286M 280M 12.29B P/E 2024
-5.58x
P/E 2025 -4x
Enterprise Value 1.04B 106M 92.67M 85.17M 79.39M 151M 10.09B 153M 1.02B 397M 4.96B 398M 389M 17.1B EV / Sales 2024
3.18x
EV / Sales 2025 3.26x
Free-Float
49.33%
Yield 2024 *
-
Yield 2025 -
1 day-1.05%
1 week+9.23%
Current month+2.90%
1 month+10.08%
3 months+0.71%
6 months-2.07%
Current year+7.58%
1 week 1.23
Extreme 1.23
1.52
1 month 1.1
Extreme 1.1
1.52
Current year 1.1
Extreme 1.1
2.01
1 year 1.1
Extreme 1.1
2.62
3 years 1.1
Extreme 1.1
3.95
5 years 1.1
Extreme 1.1
8.16
10 years 1.1
Extreme 1.1
10.95
Manager TitleAgeSince
Chief Executive Officer 53 2022-07-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 65 2009-12-31
Director TitleAgeSince
Director/Board Member 58 -
Director/Board Member 55 2015-04-30
Director/Board Member - 2021-12-02
Date Insider Type Main position Quantity % Market Cap.
23-07-13Buy 74,000 0.0187%
23-02-27Buy

Chief Technology Officer

200,000 0.0506%
23-02-16Buy

Director

100,000 0.0253%
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%+9.23%-23.24%-45.80% 76.18M
+0.12%+1.66%+6.38%-21.49% 271B
+0.14%-0.47%-12.44%-16.49% 78.19B
-0.76%+2.02%+6.61%+30.46% 54.19B
-0.46%+0.33%+37.37%+1.63% 37.01B
+2.07%+7.40%+57.48%+115.48% 35.89B
-3.07%+3.09%+2.86%-27.06% 36.95B
-3.13%+8.10%-6.25%-28.54% 30.08B
+0.91%+4.02%+22.22%+27.55% 29.29B
+0.32%-4.56%+30.80%+12.84% 20.66B
Average +0.70%+3.31%+12.18%+4.86% 59.31B
Weighted average by Cap. +0.53%+2.26%+9.72%-3.44%

Financials

2024 2025
Net sales 266M 27.01M 23.61M 21.7M 20.22M 38.36M 2.57B 38.94M 260M 101M 1.26B 101M 99.2M 4.36B 256M 26.07M 22.79M 20.95M 19.52M 37.03M 2.48B 37.59M 251M 97.75M 1.22B 97.86M 95.76M 4.2B
Net income -125M -12.74M -11.14M -10.24M -9.54M -18.1M -1.21B -18.38M -123M -47.78M -596M -47.84M -46.81M -2.06B -135M -13.72M -11.99M -11.02M -10.27M -19.49M -1.31B -19.78M -132M -51.44M -642M -51.49M -50.39M -2.21B
Net Debt 145M 14.78M 12.92M 11.87M 11.07M 20.99M 1.41B 21.31M 143M 55.41M 692M 55.47M 54.28M 2.38B 293M 29.79M 26.04M 23.93M 22.31M 42.31M 2.84B 42.95M 287M 112M 1.39B 112M 109M 4.8B
Logo Hofseth BioCare ASA
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Employees
81
Date Price Change Volume
26-07-03 NOK 1.420 -1.05% 148,128
26-07-02 NOK 1.435 +1.06% 282,570
26-07-01 NOK 1.420 +2.90% 419,645
26-06-30 NOK 1.380 +2.60% 369,475
26-06-29 NOK 1.345 +3.46% 243,658